Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eriko Kinugasa

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Clinical Chemistry and Laboratory Medicine|October 22, 2010
Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysisAlejandro Gugliucci, Eriko Kinugasa, Kazuhiko Kotani, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 4, 2014
Activation of paraoxonase 1 after hemodialysis is associated with HDL remodeling and its increase in the HDL2 fraction and VLDLAlejandro Gugliucci, Eriko Kinugasa, Hiroaki Ogata, et al.
Internal Medicine (Tokyo, Japan)|June 26, 2012
A hemodialysis patient with primary extra-gastrointestinal stromal tumor: favorable outcome with imatinib mesylateYukihiro Wada, Hiroaki Ogata, Shiho Misawa, et al.
Clinical and Experimental Nephrology|December 23, 2016
Research on kidney and mineral metabolism in Japan: past, present, and futureMasahide Mizobuchi, Hiroaki Ogata, Fumihiko Koiwa, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 17, 2007
Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patientsAlejandro Gugliucci, Nicole Lunceford, Eriko Kinugasa, et al.
Annals of Clinical Biochemistry|October 8, 2010
Serum aspirin esterase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after haemodialysisAlejandro Gugliucci, Kazuhiko Kotani, Eriko Kinugasa, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 11, 2012
Cerebral microhemorrhage in Marchiafava-Bignami disease detected by susceptibility-weighted imagingRyuta Kinno, Masahiro Yamamoto, Takahiro Yamazaki, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 21, 2011
Involvement of matrix metalloproteinase-2 in the development of medial layer vascular calcification in uremic ratsChiaki Kumata, Masahide Mizobuchi, Hiroaki Ogata, et al.
Internal Medicine (Tokyo, Japan)|October 16, 2015
False-positive results obtained for immunoglobulin M antibody tests of cerebrospinal fluid for herpes simplex virus in a patient with varicella zoster virus encephalitisRyuta Kinno, Shinji Kurokawa, Masanobu Uchiyama, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 19, 2002
Effects of 1,25-dihydroxy-22-oxavitamin D(3) on parathyroid gland function in haemodialysis patients with secondary hyperparathyroidismEriko Kinugasa, Tadao Akizawa, Junko Takahashi, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Clinical Chemistry and Laboratory Medicine|October 22, 2010
Serum paraoxonase 1 (PON1) lactonase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after hemodialysisAlejandro Gugliucci, Eriko Kinugasa, Kazuhiko Kotani, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|January 4, 2014
Activation of paraoxonase 1 after hemodialysis is associated with HDL remodeling and its increase in the HDL2 fraction and VLDLAlejandro Gugliucci, Eriko Kinugasa, Hiroaki Ogata, et al.
Internal Medicine (Tokyo, Japan)|June 26, 2012
A hemodialysis patient with primary extra-gastrointestinal stromal tumor: favorable outcome with imatinib mesylateYukihiro Wada, Hiroaki Ogata, Shiho Misawa, et al.
Clinical and Experimental Nephrology|December 23, 2016
Research on kidney and mineral metabolism in Japan: past, present, and futureMasahide Mizobuchi, Hiroaki Ogata, Fumihiko Koiwa, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 17, 2007
Acrolein inactivates paraoxonase 1: changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patientsAlejandro Gugliucci, Nicole Lunceford, Eriko Kinugasa, et al.
Annals of Clinical Biochemistry|October 8, 2010
Serum aspirin esterase activity is lower in end-stage renal disease patients than in healthy control subjects and increases after haemodialysisAlejandro Gugliucci, Kazuhiko Kotani, Eriko Kinugasa, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 11, 2012
Cerebral microhemorrhage in Marchiafava-Bignami disease detected by susceptibility-weighted imagingRyuta Kinno, Masahiro Yamamoto, Takahiro Yamazaki, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|May 21, 2011
Involvement of matrix metalloproteinase-2 in the development of medial layer vascular calcification in uremic ratsChiaki Kumata, Masahide Mizobuchi, Hiroaki Ogata, et al.
Internal Medicine (Tokyo, Japan)|October 16, 2015
False-positive results obtained for immunoglobulin M antibody tests of cerebrospinal fluid for herpes simplex virus in a patient with varicella zoster virus encephalitisRyuta Kinno, Shinji Kurokawa, Masanobu Uchiyama, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 19, 2002
Effects of 1,25-dihydroxy-22-oxavitamin D(3) on parathyroid gland function in haemodialysis patients with secondary hyperparathyroidismEriko Kinugasa, Tadao Akizawa, Junko Takahashi, et al.
Pageof 5